Liquidia (LQDA) Non-Current Assets (2019 - 2026)

Liquidia's (LQDA) quarterly Non-Current Assets came in at $68.5 million in Q1 2026, up 36.35% year-on-year from $50.2 million in Q1 2025, and up 25.57% quarter-over-quarter from $54.5 million in Q4 2025.

Liquidia (LQDA) Non-Current Assets (2019 - 2026) Analysis & Trends

Liquidia's Non-Current Assets history runs 8 years deep, the most recent figure standing at $68.5 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 36.35% year-over-year to $68.5 million in Q1 2026; TTM through Mar 2026 was $234.1 million, a 42.56% increase from a year earlier, with the FY2025 full-year figure at $54.5 million, up 20.63% from the prior year.
  • Non-Current Assets advanced to $68.5 million in Q1 2026 per LQDA's latest filing, from $54.5 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $68.5 million in Q1 2026 and bottomed at $28.4 million in Q4 2023.
  • The 5-year median for Non-Current Assets is $30.6 million (2022), against an average of $39.0 million.
  • Across the five-year window, Non-Current Assets slipped 10.08% in 2022 and surged 105.41% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $29.4 million in 2022, then dropped by 3.25% to $28.4 million in 2023, then soared by 59.0% to $45.2 million in 2024, then rose by 20.63% to $54.5 million in 2025, then advanced by 25.57% to $68.5 million in 2026.
  • Per Business Quant, the three latest LQDA Non-Current Assets figures stand at $68.5 million (Q1 2026), $54.5 million (Q4 2025), and $49.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 68.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68.48 Mn
Dec 31, 2025 54.53 Mn
Sep 30, 2025 49.26 Mn
Jun 30, 2025 61.83 Mn
Mar 31, 2025 50.22 Mn
Dec 31, 2024 45.21 Mn
Sep 30, 2024 38.67 Mn
Jun 30, 2024 30.10 Mn
Mar 31, 2024 29.18 Mn
Dec 31, 2023 28.43 Mn
Sep 30, 2023 28.66 Mn
Jun 30, 2023 28.71 Mn
Mar 31, 2023 29.23 Mn
Dec 31, 2022 29.39 Mn
Sep 30, 2022 29.51 Mn
Jun 30, 2022 30.58 Mn
Mar 31, 2022 31.57 Mn
Dec 31, 2021 32.45 Mn
Sep 30, 2021 32.82 Mn
Jun 30, 2021 33.06 Mn